Solid Biosciences Inc. (SLDB) Statistics & Valuation Metrics - Stocknear

Solid Biosciences Inc.

NASDAQ: SLDB · Real-Time Price · USD
5.50
-0.06 (-1.08%)
At close: Sep 05, 2025, 3:59 PM
5.61
2.00%
After-hours: Sep 05, 2025, 07:56 PM EDT

Solid Biosciences Statistics

Share Statistics

Solid Biosciences has 77.87M shares outstanding. The number of shares has increased by 100.84% in one year.

77.87M
100.84%
0.03%
99.99%
58.33M
1
n/a

Short Selling Information

The latest short interest is 9.78M, so 12.56% of the outstanding shares have been sold short.

9.78M
12.56%
14.93%
8.51

Valuation Ratios

The PE ratio is -1.31 and the forward PE ratio is -2.99. Solid Biosciences's PEG ratio is 0.04.

-1.31
-2.99
0
117.7
1.19
-1.62
0.04
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Solid Biosciences.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 5.2, with a Debt / Equity ratio of 0.18.

5.2
5.2
0.18
-0.2
-0.24
-381.55

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
n/a
$-1.25M
100
0
n/a

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by -34.67% in the last 52 weeks. The beta is 2.44, so Solid Biosciences's price volatility has been higher than the market average.

2.44
-34.67%
5.88
4.53
43.72
1,424,758

Income Statement

n/a
-2.46M
-129.73M
-124.7M
-121.9M
-124.36M
-3.06
Full Income Statement

Balance Sheet

The company has 80.23M in cash and 24.18M in debt, giving a net cash position of 56.06M.

80.23M
24.18M
56.06M
-783.45M
308.29M
248.79M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -100.01M and capital expenditures -654K, giving a free cash flow of -100.67M.

-100.01M
-654K
-100.67M
-2.47
Full Cash Flow Statement

Margins

n/a
n/a
n/a
n/a
n/a
n/a
n/a

Dividends & Yields

SLDB does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for SLDB is $15, which is 169.8% higher than the current price. The consensus rating is "Buy".

$15
169.8%
Buy
10
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Stock Splits

The last stock split was on Oct 28, 2022. It was a backward split with a ratio of 1:15.

Oct 28, 2022
backward
1:15

Scores

1.1
1